Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0011570 (depression)
 172,036 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The purposes of this study were: (1) to test the usefulness of intensive design in detecting the effects of an established antianxiety agent in a single patient studied for a period as brief as 8 weeks and (2) to explore the usefulness of combining intensive and extensive designs by jointly analyzing the results from several similarly treated patients. Fifteen primarily anxious, psychoneurotic patients aged 21-50 and scoring 17 or more on the Taylor Manifest Anxiety Scale were admitted to the study; and 11 completed the full treatment program. Medications were diazepam 5 mg t.i.d. and a matching placebo, administered under double-blind conditions. Patients were treated for 8 weeks, divided into 42-week blocks. In each block, the patient received diazepam 1 week and placebo the other, with the order in each block determined at random. The patient came weekly for evaluation, including, self-ratings on the Hopkins Symptom Checklist (SCL), global status, global change; reports of occupational and social function; resting pulse; reaction time; psychiatrist's ratings on the Hamilton Anxiety Scale, global status and global change. The patient also reported daily his mood on the Profile of Mood States (POMS). Mean deviations from the general trend for post-diazepam and postplacebo scores on each criterion were compared within patients. Diazepam-placebo differences on each criterion were analyzed between patients. Criteria that clearly recorded the anti-anxiety effect of diazepam as compared to placebo included the Hamilton Anxiety Scale, the psychiatrist's global status and global change ratings, the SCL Anxiety and Somatization Scales, and the POMS Anxiety Scale. Other criteria that showed a reliable diazepam effect included SCL Depression (decrease), POMS Vigor (increase), POMS Fatigue (decrease), SCL Anger (increase), and reaction time (increase). The most sensitive criteria distinguished diazepam from placebo even when results were considered only from the first 6 patients during their first 4 weeks of treatment- a total of 24 patient weeks of treatment. The factors contributing to the sensitivity of this design were investigated and discussed.
 ...
PMID:Intensive design in evaluating anxiolytic agents. 1 97

The pertinence of a rating scale capable of characterizing presenting psychopathology and measuring degrees of change for psychoneurotic patients treated in an outpatient setting is described. Data for 328 patients who represent 1191 rating profiles were used to develop the factor structure for the New Physician's Rating List, a rating scale completed by health professionals after Patient interviews. Findings were used to develop the new Brief Outpatient Psychopathology Scale. A proposed factor structure is discussed. The structures of both scales include an Anxiety Syndrome composed of Anxiety and Psychomotor Activation Factors. The scales also include Depression and Somatization factors.
 ...
PMID:The Brief Outpatient Psychopathology Scale (BOPS). 1 3

The usefulness of the Somatization factor of the MMPI-168 with low back pain patients was examined in two separate studies. In study 1, 58 male veteran low back pain patients who had been divided into organic and mixed groups served as Ss. MMPI protocols were rescored for the five factors of Overall, Hunter, and Butcher (1973). The organic and mixed groups differed only on the Somatization factor. A cutting score of raw greater than or equal to 8 (T = 75) was determined to classify the sample correctly 74.5% of the time. In study 2, a second sample of 48 male veteran low back pain patients was divided into mixed, organic, and functional groups. The mixed group was subdivided further into a mixed-pain group who still were having pain and were seeking treatment and a mixed-relief group who were experiencing a reduction of pain and were returning to vocational activities. The functional and mixed-pain groups differed from the organic and mixed-relief groups on the Somatization and Depression factors. The cutting score determined in the study 1 correctly classified patients 83% of the time.
 ...
PMID:Application of the somatization factor of the MMPI-168 with low back pain patients. 14 41

A factor analysis of the 90-item version of the Hopkins Symptom Checklist, performed on the pretreatment self-ratings of nonpsychotic outpatients with symptoms of depression and anxiety, revealed the presence of 8 clinically meaningful factors. These eight orthogonal factors each contained at least 5 items with loadings above 0.40 and explained 4.5% or more of the matrix variance. They were labeled Somatization, Phobic-Anxiety, Retarded Depression, Agitated Depression, Obsessive-Compulsive, Interpersonal Sensitivity, Anger-Hostility and Psychoticism.
 ...
PMID:The Hopkins Symptom Checklist (HSCL)--factors derived from the HSCL-90. 16 84

This study attempted to replicate previous work which used discriminant analysis to predict attrition from an outpatient alcoholism treatment program. The MMPI-168 and Rotter's locus of control scale were administered to a sample of inpatient male alcoholics who later entered outpatient treatment. The MMPI-168 was scored using 5 factor-analytically derived measures, Depression, Somatization, Low Morale, Psychotic Distortion and Acting Out. Both studies found Depression to be the strongest predictor of attrition after controlling for Somatization. Internal locus of control was also related to attrition. The utility of discriminant analysis in predicting outcome from personality data and the ramifications for treatment is discussed.
 ...
PMID:The use of multivariate personality strategies in predicting attrition from alcoholism treatment. 21 68

A new antidepressant, amoxapine, which is a dibenzoxazepine deprivative, was compared with amitriptyline in a randomised double-blind trial. Forty-eight patients were included and 41 completed a 4-week treatment. Most of the patients were maintained on 150 mg daily. Assessments were made by the Hamilton Psychiatric Rating Scale for Depression (HAM-D), Nurses' Observation Scale for Inpatient Evaluation (NOSIE), Clinical Global Impression (CGI) scale and Patient's Self-Evaluation. The total HAM-D score was considerably reduced in the majority of the patients. Amitriptyline was the most effective with regard to symptoms included in the factor Sleep Disturbances and-secondary maybe-towards some items included in the factor Somatization. For the remaining items,including the items of the factors Anxiety/Depression and Apathy, the last score was lower in the amoxapine group than in those treated with amitriptyline. Among the unipolar cases the amoxapine treated patients were more satisfied with regard to efficacy (P = 6.3%). The frequency of side effects such as tremor and dizziness was considerably lower in the amoxapine group. In total, the side effects lasted longer in the amitriptyline group. We conclude that amoxapine seems to be an effective antidepressant with a low frequency of side effects.
 ...
PMID:Amoxapine versus amitriptyline in endogenous depression. A double-blind study. 38 Feb 69

Differences between heroin and nonheroin users were determined at intake and discharge from an inpatient rehabilitation program. Background data as well as attitudes toward drug-related concepts, mood, and symptoms were gathered from 65 male veterans. Data were analyzed by analysis of variance and covariance comparing heroin and nonheroin users at intake and discharge. There were no significant differences between these two groups on their prescores, indicating that heroin and nonheroin patients were quite similar at time of intake. However, at discharge significant differences were found in terms of Tense and Thoughtful from the Mood Scale and Somatization, Obsessive/Compulsiveness, Interpersonal Sensitivity, Depression, and Anxiety from the Symptom Checklist. The heroin subjects had consistently more positive rating than the nonheroin subjects following treatment.
 ...
PMID:Differential response of heroin and nonheroin abusers to inpatient treatment. 74 72

Health is a product of culture and social structure. The routine organization and constraints of everyday settings shape our health. Socio-economic status is of major importance in determining exposure to disease risk and in shaping health and illness behavior responses. Lay explanations of illness affect illness appraisal, self-treatment, decisions to seek care and changes in daily regimen. Somatization of psychosocial stressors is a common concern in primary care systems throughout the world, and doctors are commonly frustrated by such patients. Somatizing patients are often enmeshed in environments of great psychosocial difficulty or are depressed, and many cultural and social factors affect how depression is expressed. Although depression has devastating disabling effects on patients, it is often neither recognized by doctors nor treated. But doctor-patient relationships are often the context for appropriate management of such problems, and how they are handled affect the future trajectory of illness and disability. Doctors' responses are conditioned by their attitudes, training, interviewing and psychosocial skills, and organizational and financial factors. Patient flow is an important intervening variable affecting the management of psychosocial difficulties and depression.
 ...
PMID:Health and illness behavior and patient-practitioner relationships. 152 72

In a longitudinal study of personality, 66 women completed the Cesarec Marke Personality Schedule, a Swedish personality inventory, in order to asses their psychogenic needs at the age of 15 and 25. Psychiatric symptoms and a number of background variables were assessed independently after the completion of the Cesarec Marke Personality Schedule, with the aim of examining whether traits and background variables were related to psychiatric symptoms. The psychogenic needs Defence of Status and Guilt Feelings at the age of 15 were positively and significantly related to depressive and anxiety symptoms and high score on psychiatric morbidity in general. The psychogenic needs Defence of Status, Guilt Feelings and Succourance at the age of 25 were significantly related to the symptom constructs Somatization, Interpersonal-sensitivity, Depression, Anxiety-phobia, and General Morbidity. Subjects with a low score of psychiatric symptoms differed from high scoring subjects by having been raised by older parents, experienced a secure childhood, better relationships with siblings and peers, and a longer education. It may be hypothesized that high scores on Defence of Status and Guilt Feelings in combination with less favourable background variables may constitute a vulnerability factor for depression and anxiety.
 ...
PMID:Psychogenic needs and psychiatric symptoms in young Swedish women. 157 4

Physical and psychosocial function have rarely been assessed in syncope. We used two valid and reliable measures of health status, the Sickness Impact Profile (SIP) and the Symptom Checklist 90 (SCL-90-R), to assess functional impairment in 62 patients with recurrent syncope seen in a syncope specialty clinic. Mean total SIP scores were markedly elevated at 17 (SD = 14), indicating a level of impairment similar to severe rheumatoid arthritis and chronic low back pain. SIP psychosocial scores were significantly greater than SIP physical scores (20 vs 11, p less than 0.0001). SCL-90-R scores were also high, comparable to those of psychiatric inpatients. Somatization, anxiety and depression dimensions of the SCL-90-R were particularly elevated. SCL-90-R subscale scores were highly correlated with SIP psychosocial scores (all r greater than 0.4, and p less than 0.001). Neither age nor number of comorbid diseases correlated with measures of psychosocial function, suggesting that syncope itself causes psychosocial impairment. Although this was a referral population, these data suggest that function can be seriously impaired by syncope, that the degree of impairment is similar to that reported in other chronic diseases, and that syncope leads to significantly greater psychosocial than physical impairment.
 ...
PMID:Impairment of physical and psychosocial function in recurrent syncope. 194 Sep 96


1 2 3 4 5 6 7 8 9 10 Next >>